ClinConnect ClinConnect Logo
Search / Trial NCT06924307

Parent-Child EF Intervention

Launched by KORONIS BIOMEDICAL TECHNOLOGIES · Apr 10, 2025

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

Executive Function

ClinConnect Summary

The Parent-Child EF Intervention trial is studying a new program designed to help young children, ages 2 to 5, develop important skills known as Executive Function (EF) skills. These skills include things like focusing attention, controlling impulses, and planning ahead, which are crucial for healthy development. The program uses a smartphone-based training designed for parents to engage with their children in fun and educational activities that support these skills.

To participate in this trial, children need to be between the ages of 2 and 5, and they must have a caregiver or guardian who can help. However, children with certain physical disabilities or severe developmental delays are not eligible. It’s also important that parents or caregivers can read and understand English. If selected, families can expect to take part in activities that can help their child grow and learn while having fun together. The trial is currently recruiting participants, so it's a great opportunity to be part of a program aimed at fostering healthy development in young children!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children ages 2-5 years.
  • Caregivers/guardian of the participating child.
  • Exclusion Criteria:
  • Children with physical disabilities affecting vision, hearing, or basic mobility.
  • Children with severe developmental delays or disorders
  • Parents or caregivers who cannot read and understand English

About Koronis Biomedical Technologies

Koronis Biomedical Technologies is a pioneering clinical trial sponsor dedicated to advancing innovative therapeutic solutions in the biomedical field. Focused on developing cutting-edge treatments, the organization leverages state-of-the-art technology and rigorous scientific methodologies to conduct clinical trials that prioritize patient safety and efficacy. With a commitment to collaboration and transparency, Koronis Biomedical Technologies aims to accelerate the development of transformative therapies, ultimately improving health outcomes and enhancing the quality of life for patients worldwide.

Locations

Minneapolis, Minnesota, United States

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Stephanie M. Carlson, PhD

Principal Investigator

University of Minnesota

Blair Hammond, MD

Principal Investigator

Mount Sinai General Pediatrics

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported